ArticleJournal of orthopaedics
Long-term clinical results of bipolar hemiarthroplasty for osteoarthritis and rheumatoid arthritis of the hip: A retrospective study.
Article in Journal of orthopaedics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 2 citations in OpenAlex.
- Total Hip Arthroplasty for Neglected Pathological Femoral Neck Fracture in a Young Patient with Autoimmune Polyglandular Syndrome.Journal of orthopaedic case reports · 2026Article
- Cemented Modular Bipolar Hemiarthroplasty for Displaced Femoral Neck Fractures in the Elderly.Cureus · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We aimed to clarify the possibility of using bipolar hip arthroplasty (BHA) for degenerative diseases by examining long-term results postoperatively in 336 hips. Patients' average age was 61.0 years (range, 34-88 years), and the average follow-up period was 12.5 years (range, 5.0-27.3 years). The 5-year, 10-year, and 20-year Kaplan Meier survival rates (end point: revision) were 92.1%, 81.8%, and 20.1% in the osteoarthritis group and 96.4%, 90.1%, and 24.6% in the rheumatoid arthritis group, respectively. Since the survival rate for more than 10 years decreases rapidly, the use of BHA for treating degenerative diseases should be restricted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.